A Phase Ⅱ Clinical Study Trial of Felbinac Trometamol Injection in China

PHASE2CompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

March 27, 2019

Primary Completion Date

September 30, 2019

Study Completion Date

December 5, 2019

Conditions
Pain
Interventions
DRUG

Felbinac Trometamol Injection

"Felbinac Trometamol Injection diluted to 100 ml with 0.9% sodium chloride injection,a 30-minute period using a Microinjection pump.~One dose at 8h and 16h after the start of the first dose,the first intravenous infusion was started at the end of the operation (Skin suture completes the last stitch).the drug was given 3 times,3 times/day,once every 8 hours."

DRUG

Placebos

"Placebo diluted to 100 ml with 0.9% sodium chloride injection,a 30-minute period using a Microinjection pump.~One dose at 8h and 16h after the start of the first dose,the first intravenous infusion was started at the end of the operation (Skin suture completes the last stitch).the drug was given 3 times,3 times/day,once every 8 hours."

Trial Locations (1)

050036

Shijiazhuang Yiling Pharmaceutical Co.,Ltd, Shijiazhuang

All Listed Sponsors
lead

Shijiazhuang Yiling Pharmaceutical Co. Ltd

INDUSTRY

NCT03872830 - A Phase Ⅱ Clinical Study Trial of Felbinac Trometamol Injection in China | Biotech Hunter | Biotech Hunter